The potential of iosulamide meglumine as a contrast material for intravenous cholangiography: an experimental study in dogs.
Because of relatively low acute toxicity, iosulamide meglumine has been recommended as an improved contrast material for intravenous cholangiography. It has been postulated that high doses of the compound could be given safely with the expectation of achieving greater biliary excretion and improved opacification of the biliary tree. Experiments performed in dogs show that higher rates of infusion of iosulamide result in greater urinary elimination without additional biliary excretion. Consequently, iosulamide is unlikely to have any special advantage as a contrast agent.
D000818:Animals; D002758:Cholangiography / Q000379:methods*; D003287:Contrast Media / Q000008:administration & dosage*; D003973:Diatrizoate / Q000031:analogs & derivatives*; D003974:Diatrizoate Meglumine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004285:Dogs; D007275:Injections, Intravenous; D007458:Iodipamide / Q000008:administration & dosage / Q000378:metabolism
D003287:Contrast Media; D003973:Diatrizoate; C028779:iosulamide meglumine; D003974:Diatrizoate Meglumine; D007458:Iodipamide